References
- Feemster KA, Kim Y, Abe M, et al., Response to Igarashi, et al. Cost-effectiveness analysis for PCV13 in adults 60 years and over with underlying medical conditions which put them at an elevated risk of pneumococcal disease in Japan. Exp Rev Vaccines 2021;21(5):1–2. DOI: https://doi.org/10.1080/14760584.2022.2036127
- Suzuki M, Dhoubhadel BG, Ishifuji T, et al. Serotype-specific effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia in adults aged 65 years or older: a multicentre, prospective, test-negative design study. Lancet Infect Dis. 2017;17(3):313–321.
- Kim JH, Chun BC, Song JY, et al. Direct effectiveness of pneumococcal polysaccharide vaccine against invasive pneumococcal disease and non-bacteremic pneumococcal pneumonia in elderly population in the era of pneumococcal conjugate vaccine: a case-control study. Vaccine. 2019 May 9;37(21):2797–2804.
- Heo JY, Seo, YB, Choi, WS, et al. Effectiveness of pneumococcal vaccination against hospitalized pneumococcal pneumonia in older adults: a prospective, test-negative study. J Infect Dis. 2021 Sep 19;jiab474. Online ahead of print. DOI:https://doi.org/10.1093/infdis/jiab474.
- Diseases NIoI. 23-valent pneumococcal polysaccharide vaccine fact sheet. 2018. [cited 2021 December 24]. https://www.mhlw.go.jp/file/05-Shingikai-10601000-Daijinkanboukouseikagakuka-Kouseikagakuka/0000184910_1.pdf
- Matanock A, Lee G, Gierke R, et al. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: updated recommendations of the advisory committee on immunization practices. MMWR. 2019;68(46):1069–1075.
- National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport, Netherland. Information for policy makers. [ cited 2021 December 24]. https://www.rivm.nl/en/pneumococci/information-for-policy-makers
- Haut Conseil de la Santé Publique. Infections à pneumocoque: recommandations vaccinales pour les adultes. Avis mis à jour le 27 Nov 2017. [cited 2021 December 24]. https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=636